International Journal of Cancer Management

Published by: Kowsar
Crossmark

National Cancer Mortality-to-Incidence Ratio (MIR) in Iran (2005 - 2014)

Atieh Akbari ORCID 1 , Maryam Khayamzadeh ORCID 1 , * , Reza Salmanian 1 , Ali Ghanbari Motlagh 1 , 2 , Gholamreza Roshandel 3 , Maryam Nouri 1 and Mohammad Esmaeil Akbari ORCID 1
Authors Information
1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Mortazavi (Jorjiani) Radiation Oncology Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
Article information
  • International Journal of Cancer Management: June 30, 2019, 12 (6); e94145
  • Published Online: July 1, 2019
  • Article Type: Research Article
  • Received: May 20, 2019
  • Revised: June 22, 2019
  • Accepted: June 22, 2019
  • DOI: 10.5812/ijcm.94145

To Cite: Akbari A, Khayamzadeh M, Salmanian R, Ghanbari Motlagh A, Roshandel G, et al. National Cancer Mortality-to-Incidence Ratio (MIR) in Iran (2005 - 2014), Int J Cancer Manag. 2019 ; 12(6):e94145. doi: 10.5812/ijcm.94145.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. World Health Organization. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. International Agency for Research on Cancer; 2018, [cited 12 September 2018]. Available from: https://www.iarc.fr/wp-content/uploads/2018/09/pr263_E.pdf.
  • 2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492. [PubMed: 30207593].
  • 3. Poudel KK, Huang Z, Neupane PR. Age specific incidence of five major cancers in Nepal, 2012. Nepal J Epidemiol. 2016;6(2):565-73. doi: 10.3126/nje.v6i2.15163. [PubMed: 27774345]. [PubMed Central: PMC5073174].
  • 4. Poudel KK, Huang Z, Neupane PR, Steel R. Changes in the distribution of cancer incidence in Nepal from 2003 to 2013. Asian Pac J Cancer Prev. 2016;17(10):4775-82. doi: 10.22034/apjcp.2016.17.10.4775. [PubMed: 27893211]. [PubMed Central: PMC5454631].
  • 5. Global Burden of Disease Cancer Collaboration , Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524-48. doi: 10.1001/jamaoncol.2016.5688. [PubMed: 27918777]. [PubMed Central: PMC6103527].
  • 6. Sandagdorj T, Sanjaajamts E, Tudev U, Oyunchimeg D, Ochir C, Roder D. Cancer incidence and mortality in Mongolia - National Registry Data. Asian Pac J Cancer Prev. 2010;11(6):1509-14. [PubMed: 21338189].
  • 7. Amirkhah R, Naderi-Meshkin H, Mirahmadi M, Allahyari A, Sharifi HR. Cancer statistics in Iran: Towards finding priority for prevention and treatment. Cancer Press. 2017;3(2):27-38.
  • 8. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0. [PubMed: 23245604].
  • 9. World Health Organization. Cancer. 2014. Available from: https://www.who.int/topics/cancer/en/.
  • 10. Sowunmi A, Alabi A, Fatiregun O, Olatunji T, Okoro US, Durosinmi Etti AF. Trend of cancer incidence in an oncology center in Nigeria. West Afr J Radiol. 2018;25(1):52. doi: 10.4103/wajr.wajr_26_17.
  • 11. Choi E, Lee S, Nhung BC, Suh M, Park B, Jun JK, et al. Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries. Epidemiol Health. 2017;39. e2017006. doi: 10.4178/epih.e2017006. [PubMed: 28171715]. [PubMed Central: PMC5434228].
  • 12. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16-27. doi: 10.1158/1055-9965.EPI-15-0578. [PubMed: 26667886].
  • 13. Xu Z, Zhou H, Lei L, Li H, Yu W, Fu Z, et al. Incidence of cancer in Shenzhen, Guangdong province during 2001-2015: A retrospective population-based study. Int J Environ Res Public Health. 2017;14(10). doi: 10.3390/ijerph14101137. [PubMed: 28953262]. [PubMed Central: PMC5664638].
  • 14. Li CY, Ye YC, Liang GY, Zhang WH, Zhang ZY, Liu XQ, et al. Cancer incidence and mortality survey in Wuwei, Gansu province, Northwestern China from 2003 to 2012: A retrospective population-based study. Chin Med J (Engl). 2016;129(6):636-44. doi: 10.4103/0366-6999.177969. [PubMed: 26960365]. [PubMed Central: PMC4804408].
  • 15. G. B. D. Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-88. doi: 10.1016/S0140-6736(18)32203-7. [PubMed: 30496103]. [PubMed Central: PMC6227606].
  • 16. Mohebbi E, Nahvijou A, Hadji M, Rashidian H, Seyyedsalehi MS, Nemati S. Iran cancer statistics in 2012 and projection of cancer incidence by 2035. Basic Clin Cancer Res. 2017;9(3):3-22.
  • 17. Khader YS, Sharkas GF, Arkoub KH, Alfaqih MA, Nimri OF, Khader AM. The epidemiology and trend of cancer in Jordan, 2000-2013. J Cancer Epidemiol. 2018;2018:2937067. doi: 10.1155/2018/2937067. [PubMed: 30416523]. [PubMed Central: PMC6207872].
  • 18. Amoori N, Mirzaei M, Cheraghi M. Incidence of cancers in Kuzestan province of Iran: Trend from 2004 to 2008. Asian Pac J Cancer Prev. 2014;15(19):8345-9. doi: 10.7314/apjcp.2014.15.19.8345. [PubMed: 25339027].
  • 19. Amori N, Aghajani M, Asgarian FS, Jazayeri M. Epidemiology and trend of common cancers in Iran (2004-2008). Eur J Cancer Care (Engl). 2017;26(5). doi: 10.1111/ecc.12449. [PubMed: 26811194].
  • 20. El Mistiri M, Salati M, Marcheselli L, Attia A, Habil S, Alhomri F, et al. Cancer incidence, mortality, and survival in Eastern Libya: Updated report from the Benghazi Cancer Registry. Ann Epidemiol. 2015;25(8):564-8. doi: 10.1016/j.annepidem.2015.03.012. [PubMed: 25911981].
  • 21. Hashim D, Boffetta P, La Vecchia C, Rota M, Bertuccio P, Malvezzi M, et al. The global decrease in cancer mortality: Trends and disparities. Ann Oncol. 2016;27(5):926-33. doi: 10.1093/annonc/mdw027. [PubMed: 26802157].
  • 22. Yilmaz HH, Yazihan N, Tunca D, Sevinc A, Olcayto EO, Ozgul N, et al. Cancer trends and incidence and mortality patterns in Turkey. Jpn J Clin Oncol. 2011;41(1):10-6. doi: 10.1093/jjco/hyq075. [PubMed: 20558464].
  • 23. Lee HL, Peng CM, Huang CY, Wu SY, Tsai MC, Wang CC, et al. Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries. BMJ Open. 2018;8(7). e020618. doi: 10.1136/bmjopen-2017-020618. [PubMed: 29982202]. [PubMed Central: PMC6042615].
  • 24. Fidler MM, Soerjomataram I, Bray F. A global view on cancer incidence and national levels of the human development index. Int J Cancer. 2016;139(11):2436-46. doi: 10.1002/ijc.30382. [PubMed: 27522007].
  • 25. Yepez MC, Jurado DM, Bravo LM, Bravo LE. Trends on cancer incidence and mortality in Pasto, Colombia. 15 years experience. Colomb Med (Cali). 2018;49(1):42-54. doi: 10.25100/cm.v49i1.3616. [PubMed: 29983463]. [PubMed Central: PMC6018824].
  • 26. Almasi SZ, Salehiniya H, Amoori N, Mahdavi S, Enayatrad M. Trends in the incidence of cancer in Iran (2003 - 2009). Iran J Cancer Prev. 2017;10(2):1-6. doi: 10.5812/ijcp.4715.
  • 27. Almasi Z, Mohammadian-Hafshejani A, Salehiniya H. Incidence, mortality, and epidemiological aspects of cancers in Iran; differences with the world data. J BUON. 2016;21(4):994-1004. [PubMed: 27685925].
  • 28. Mohammadian M, Salehiniya H, Mohammadian-Hafshejani A. Some facts on incidence and mortality of cancer in Iran. Iran J Public Health. 2017;46(10):1446-7. [PubMed: 29308393]. [PubMed Central: PMC5750361].
  • 29. Masoompour SM, Lankarani KB, Honarvar B, Tabatabaee SH, Moghadami M, Khosravizadegan Z. Changing epidemiology of common cancers in Southern Iran, 2007-2010: A cross sectional study. PLoS One. 2016;11(5). e0155669. doi: 10.1371/journal.pone.0155669. [PubMed: 27219458]. [PubMed Central: PMC4878731].
  • 30. Sharma R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: Evidence from Global Burden of Disease Study 2016. Breast Cancer. 2019;26(4):428-45. doi: 10.1007/s12282-018-00941-4. [PubMed: 30604398].
  • 31. Chen JG, Zhu J, Parkin DM, Zhang YH, Lu JH, Zhu YR, et al. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer. 2006;119(6):1447-54. doi: 10.1002/ijc.21952. [PubMed: 16596645].
  • 32. Statistical Center of Iran. Statistical Center of Iran. 2019. Available from: https://www.amar.org.ir/.
  • 33. Segi M, Tōhoku D, Nippon Taigan K. Cancer mortality for selected sites in 24 countries. Nagoya, Japan [etc.]: Japan Cancer Society [etc.]; 1950.
  • 34. [No Author Listed]. Visit report. 2019. Available from: www.visit_report.com.
  • 35. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8. [PubMed: 23245609]. [PubMed Central: PMC4156511].
  • 36. World Health Organization. Global health observatory data repository. Geneva: WHO; 2013. Available from: http://apps.who.int/gho/data/node.main.a859lang=en.
  • 37. Bray F, Soerjomataram I. The changing Global Burden of Cancer: Transitions in human development and implications for cancer prevention and control. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC); 2015. eng. doi: 10.1596/978-1-4648-0349-9_ch2.
  • 38. G. B. D. Population Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1995-2051. doi: 10.1016/S0140-6736(18)32278-5. [PubMed: 30496106]. [PubMed Central: PMC6227915].
  • 39. Doll R. Are we winning the fight against cancer? An epidemiological assessment. EACR--Muhlbock memorial lecture. Eur J Cancer. 1990;26(4):500-8. [PubMed: 2141517].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments